Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.40B | 8.01B | 6.46B | 14.46B | 14.06B | 14.35B | Gross Profit |
8.01B | 6.14B | 5.14B | 3.78B | 2.61B | 2.22B | EBIT |
1.22B | 1.54B | 2.46B | 738.58M | 195.67M | -91.49M | EBITDA |
3.47B | 2.28B | 2.96B | 1.31B | 537.96M | 142.50M | Net Income Common Stockholders |
1.86B | 1.03B | 2.11B | 335.86M | 101.71M | -178.87M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.49B | 2.50B | 2.88B | 1.48B | 1.09B | 1.20B | Total Assets |
19.24B | 19.20B | 17.86B | 7.34B | 5.65B | 4.27B | Total Debt |
8.07B | 8.07B | 8.89B | 2.24B | 1.37B | 426.06M | Net Debt |
5.61B | 5.57B | 6.02B | 760.46M | 277.50M | -771.48M | Total Liabilities |
11.95B | 11.91B | 12.82B | 4.60B | 2.99B | 1.72B | Stockholders Equity |
7.25B | 7.25B | 4.99B | 2.72B | 2.66B | 2.54B |
Cash Flow | Free Cash Flow | ||||
1.70B | 279.72M | 630.17M | 417.46M | -164.41M | -272.45M | Operating Cash Flow |
2.20B | 1.14B | 1.39B | 1.14B | 431.30M | 73.11M | Investing Cash Flow |
-1.12B | -831.13M | -5.97B | -1.27B | -1.46B | -415.37M | Financing Cash Flow |
-915.17M | -836.98M | 5.93B | 483.71M | 912.44M | -76.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥20.47B | 11.85 | 1.67% | -5.81% | 1585.94% | ||
66 Neutral | ¥7.89B | 13.37 | 4.13% | -2.17% | 25.33% | ||
62 Neutral | ¥16.63B | 10.36 | ― | 41.30% | 127.51% | ||
61 Neutral | $14.08B | 5.95 | -4.18% | 3.68% | 2.79% | -36.29% | |
48 Neutral | ¥8.12B | ― | 5.38% | 6.34% | -367.86% |